인쇄하기
취소
|
Ahead of a regular flu season, the drug industry has had a ‘great war’ over ‘Tamiflu’ generic medicines.
After the Roche’s influenza treatment Tamiflu’s patent was expired on the last 22nd of August, about 30 Korean pharmaceutical companies have acquired approval for approximately 100 Tamiflu generics.
Tamiflu has a market size of about KRW 60 billion in Korea, and Hami Flu, which had an earl...